Unknown

Dataset Information

0

High yield purification of Helicobacter pylori neutrophil-activating protein overexpressed in Escherichia coli.


ABSTRACT: Helicobacter pylori neutrophil-activating protein (HP-NAP) is involved in H. pylori-induced gastric inflammation. Due to its immunogenic and immunomodulatory properties, HP-NAP has been used for developing vaccines against H. pylori infection and new drugs for cancer therapy.Here, we provide a simple process for high-yield production of HP-NAP by applying one-step negative chromatography to purify recombinant HP-NAP expressed in Escherichia coli (E. coli). In our E. coli expression system, recombinant HP-NAP constitutes nearly 70% of the total protein. Overexpressed recombinant HP-NAP is almost completely soluble upon cell lysis at pH 9.5. Under the optimal condition at pH 8.0, recombinant HP-NAP with purity higher than 95% can be obtained from E. coli by collecting the unbound fraction using diethylaminoethyl (DEAE) Sephadex resin in batch mode. The overall yield of HP-NAP from a 50-ml E. coli culture is ~19 mg. The purified HP-NAP folds into a multimer with a secondary structure of ?-helix and is able to trigger the production of reactive oxygen species by neutrophils.Purification of recombinant HP-NAP overexpressed in E. coli using DEAE Sephadex negative mode batch chromatography is an efficient method for high-yield production of highly pure HP-NAP in its native state. The purified HP-NAP is useful for various clinical applications including vaccine development, diagnosis, and new drug development.

SUBMITTER: Yang YC 

PROVIDER: S-EPMC4425898 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

High yield purification of Helicobacter pylori neutrophil-activating protein overexpressed in Escherichia coli.

Yang Yu-Chi YC   Kuo Ting-Yu TY   Hong Zhi-Wei ZW   Chang Han-Wen HW   Chen Chung-Chu CC   Tsai Te-Lung TL   Fu Hua-Wen HW  

BMC biotechnology 20150408


<h4>Background</h4>Helicobacter pylori neutrophil-activating protein (HP-NAP) is involved in H. pylori-induced gastric inflammation. Due to its immunogenic and immunomodulatory properties, HP-NAP has been used for developing vaccines against H. pylori infection and new drugs for cancer therapy.<h4>Results</h4>Here, we provide a simple process for high-yield production of HP-NAP by applying one-step negative chromatography to purify recombinant HP-NAP expressed in Escherichia coli (E. coli). In o  ...[more]

Similar Datasets

| S-EPMC3620106 | biostudies-literature
| S-EPMC173288 | biostudies-other
| S-EPMC4205362 | biostudies-literature
| S-EPMC1874666 | biostudies-literature
| S-EPMC4450655 | biostudies-literature
| S-EPMC107925 | biostudies-literature
| S-EPMC6718361 | biostudies-literature
| S-EPMC3274388 | biostudies-literature
| S-EPMC168813 | biostudies-other
| S-EPMC3691681 | biostudies-literature